THOMAS JEFFERSON UNIVERSITY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 99157
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 62105
 
  
 
C07K PEPTIDES 4789
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3887
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 3465
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 25181
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1980
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1283
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 10230
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 10144

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0000,784 PAR4 INHIBITOR THERAPY FOR PATIENTS WITH PAR4 POLYMORPHISMSep 13, 17Jan 04, 18[A61K, C12Q]
2017/0314,076 SPECIFIC EXPRESSION OF HALF-TRNA IN CANCERSFeb 04, 15Nov 02, 17[C12Q]
2017/0268,071 COMPOSITIONS AND METHODS OF USING TRANSFER RNAS (tRNAs)Oct 27, 15Sep 21, 17[C12Q]
2017/0175,123 Diagnosis And Treatment Of Cancers With MicroRNA Located In Or Near Cancer-Associated Chromosomal FeaturesAug 15, 16Jun 22, 17[C12Q, C12N]
2017/0088,597 INTERLEUKIN-15 SUPERAGONIST SIGNIFICANTLY ENHANCES GRAFT-VERSUS-TUMOR ACTIVITYSep 23, 16Mar 30, 17[A61K, C07K]
2016/0192,948 ANGLED CRANIOTOME AND MINIMAL PLATING SYSTEM FOR IMPROVED COSMESIS AND STRUCTURAL INTEGRITY OF CRANIOTOMIESSep 06, 14Jul 07, 16[A61B]
2016/0139,132 Method of Diagnosis or Prognosis of a Neoplasm Comprising Determining the Level of Expression of a Protein in Stromal Cells Adjacent to the NeoplasmDec 10, 15May 19, 16[A61K, G01N]
2016/0074,389 CAVEOLIN-1 RELATED METHODS FOR TREATING GLIOBLASTOMA WITH TEMOZOLOMIDEApr 18, 14Mar 17, 16[A61K, C12Q, G01N]
2016/0041,170 METHOD FOR DETECTING SHED OR CIRCULATING TUMOR CELLS IN BIOLOGICAL FLUIDSFeb 11, 14Feb 11, 16[G01N]
2015/0374,861 KIT FOR TUMOR IMAGINGFeb 11, 14Dec 31, 15[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9889192 Immunization with rabies virus vector expressing foreign protein antigenSep 24, 13Feb 13, 18[A61K, C12N, C07K]
9884067 Androgen receptor down-regulating agents and uses thereofMar 14, 14Feb 06, 18[A61K, A61N, C07J]
9880150 E2F reporter melanoma cellsJan 28, 16Jan 30, 18[A61K, C12Q, G01N]
9873747 Fusion proteins that facilitate cancer cell destructionJan 31, 14Jan 23, 18[A61K, C07K]
9834610 Fusion proteins for modulating regulatory and effector T cellsJan 31, 14Dec 05, 17[A61K, C07K]
9814413 Long-term implantable monitoring system and methods of useJul 24, 15Nov 14, 17[A61B, A61M]
9789074 Composition and method for muscle repair and regenerationAug 31, 11Oct 17, 17[A61K]
9789087 PAR4 inhibitor therapy for patients with PAR4 polymorphismAug 02, 16Oct 17, 17[A61K, C12Q]
9777055 Engineered antibody for inhibition of fibrosisFeb 26, 13Oct 03, 17[A61K, C07K]
9750757 Methods of prevention or treatment for pathologic thrombosis or inflammationOct 27, 14Sep 05, 17[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0049,869 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal OriginAbandonedAug 26, 16Feb 23, 17[A61K, C12N, C07K]
2016/0038,526 TREATMENT OF PROSTATE CANCERAbandonedMay 10, 13Feb 11, 16[A61K, A61N]
2015/0240,240 MSF REPROGRAMS MYOFIBROBLASTS TOWARD LACTATE PRODUCTION AND FUEL ANAERBOIC TUMOR GROWTHAbandonedSep 13, 13Aug 27, 15[C12N]
2015/0231,167 TREATMENT OF HEMATOLOGICAL NEOPLASMSAbandonedMay 10, 13Aug 20, 15[A61K]
2015/0209,379 TREATMENT OF PROSTATE CANCER AND HEMATOLOGIC NEOPLASMSAbandonedMay 10, 13Jul 30, 15[A61K]
2014/0322,705 Cancer diagnostic and cancer therapeuticAbandonedAug 19, 11Oct 30, 14[C12Q, G01N]
2014/0271,550 Constructs and Methods for Delivering Molecules via Viral Vectors with Blunted Innate Immune ResponsesAbandonedMar 14, 14Sep 18, 14[C12N]
2014/0255,518 Treatment and Prevention of Gastrointestinal SyndromeAbandonedApr 27, 12Sep 11, 14[A61K, C07K]
2014/0221,496 Method of Diagnosis or Prognosis of a Neoplasm Comprising Determining the Level of Expression of a Protein in Stromal Cells Adjacent to the NeoplasmAbandonedNov 26, 13Aug 07, 14[A61K]
2014/0213,534 INTESTINAL HYPERPERMEABILITY AND PREVENTION OF SYSTEMIC DISEASEAbandonedApr 27, 12Jul 31, 14[A61K]
2014/0179,796 MARKERS FOR DCIS RECURRENCE: COORDINATE PTEN/RB LOSSAbandonedDec 18, 13Jun 26, 14[C12Q, G01N]
2014/0107,390 IMPLEMENTATION AND EXPERIMENTAL RESULTS OF REAL-TIME 4D TUMOR TRACKING USING MULTI-LEAF COLLIMATOR (MLC), AND/OR MLC-CARRIAGE (MLC-BANK), AND/OR TREATMENT TABLE (COUCH)AbandonedOct 12, 12Apr 17, 14[G06F, A61N]
2014/0038,197 SYSTEM FOR AND METHOD OF DETERMINING CANCER PROGNOSIS AND PREDICTING RESPONSE TO THERAPYAbandonedJan 09, 12Feb 06, 14[C12Q, G06F]
2014/0026,234 BIOMARKERS AND THEIR USES IN CANCER DETECTION AND THERAPYAbandonedJan 27, 12Jan 23, 14[G01N, A01K]
2013/0317,083 NON-CODING TRANSCRIPTS FOR DETERMINATION OF CELLULAR STATESAbandonedMay 03, 13Nov 28, 13[C12Q]
2013/0172,430 PROGNOSIS AND TREATMENT OF BREAST CANCERAbandonedDec 08, 11Jul 04, 13[A61K, C12Q, G01N]
2013/0150,379 METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERSAbandonedMar 14, 11Jun 13, 13[A61K]
8445650 Mutant botulinum neurotoxin serotype A polypeptide and uses thereofExpiredSep 25, 08May 21, 13[A61K, C12P]
2013/0096,159 INHIBITORS OF HUMAN 12-LIPOXYGENASEAbandonedMay 18, 11Apr 18, 13[C07D]
2012/0308,583 USE OF GCC LIGANDSAbandonedJun 19, 12Dec 06, 12[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.